Supplemental material
Journal of Pharmaceutical Policy and Practice
Volume 17, 2024 - Issue 1
Research Article
Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: a cost-effectiveness analysis
Wei Kanga Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People’s Republic of China
https://orcid.org/0000-0002-7617-6323View further author information
https://orcid.org/0000-0002-7617-6323View further author information, , Vincent K.C. Yana Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People’s Republic of Chinahttps://orcid.org/0000-0001-5225-3032View further author information
https://orcid.org/0000-0001-5225-3032View further author information, Daoud Al-Badriyehc College of Pharmacy, QU Health, Qatar University, Doha, Qatarhttps://orcid.org/0000-0001-7791-954XView further author information
https://orcid.org/0000-0001-7791-954XView further author information, Shing Fung Leed Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singaporehttps://orcid.org/0000-0003-4696-9434View further author information
https://orcid.org/0000-0003-4696-9434View further author information, Hei Hang Edmund Yiua Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People’s Republic of Chinahttps://orcid.org/0000-0002-1492-9414View further author information
https://orcid.org/0000-0002-1492-9414View further author information, Yue Weia Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People’s Republic of Chinahttps://orcid.org/0000-0002-8763-6786View further author information
https://orcid.org/0000-0002-8763-6786View further author information, Silvia T. H. Lia Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People’s Republic of Chinahttps://orcid.org/0000-0001-8280-2952View further author information
https://orcid.org/0000-0001-8280-2952View further author information, Xuxiao Yea Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People’s Republic of Chinahttps://orcid.org/0000-0002-9316-4666View further author information
https://orcid.org/0000-0002-9316-4666View further author information, Aya El Helalie Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People’s Republic of Chinahttps://orcid.org/0000-0001-6427-114XView further author information
https://orcid.org/0000-0001-6427-114XView further author information, , Victor H. F. Leee Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People’s Republic of China;f Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People’s Republic of Chinahttps://orcid.org/0000-0002-6283-978XView further author information
https://orcid.org/0000-0002-6283-978XView further author information, Ian C. K. Wonga Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People’s Republic of China;g Laboratory of Data Discovery for Health (D4H), Hong Kong Science and Technology Park, Hong Kong SAR, People’s Republic of China;h School of Pharmacy, Aston University, Birmingham, UK;i School of Pharmacy, Medical Sciences Division, Macau University of Science and Technology, Macau SAR, People’s Republic of China;k Department of Pharmacy, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People’s Republic of Chinahttps://orcid.org/0000-0001-8242-0014View further author information
https://orcid.org/0000-0001-8242-0014View further author information & Esther W. Chana Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People’s Republic of China;g Laboratory of Data Discovery for Health (D4H), Hong Kong Science and Technology Park, Hong Kong SAR, People’s Republic of China;j The University of Hong Kong Shenzhen Institute of Research and Innovation, Shenzhen, People’s Republic of China;k Department of Pharmacy, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-7602-9470View further author information
https://orcid.org/0000-0002-7602-9470View further author information show all